nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—CACNA2D2—mammary gland—lung cancer	0.0142	0.117	CbGeAlD
Gabapentin—CACNA1B—respiratory system—lung cancer	0.0131	0.108	CbGeAlD
Gabapentin—BCAT1—respiratory system—lung cancer	0.0103	0.085	CbGeAlD
Gabapentin—CACNA2D1—mammary gland—lung cancer	0.0102	0.0841	CbGeAlD
Gabapentin—CACNA2D2—respiratory system—lung cancer	0.00945	0.0779	CbGeAlD
Gabapentin—BCAT1—trachea—lung cancer	0.00762	0.0628	CbGeAlD
Gabapentin—CACNA1B—lung—lung cancer	0.00696	0.0574	CbGeAlD
Gabapentin—CACNA2D2—cardiac atrium—lung cancer	0.00656	0.0541	CbGeAlD
Gabapentin—BCAT1—lung—lung cancer	0.00547	0.0451	CbGeAlD
Gabapentin—CACNA2D2—lung—lung cancer	0.00502	0.0414	CbGeAlD
Gabapentin—CACNA1B—lymph node—lung cancer	0.00476	0.0392	CbGeAlD
Gabapentin—ADORA1—cardiac atrium—lung cancer	0.00455	0.0375	CbGeAlD
Gabapentin—CACNA2D1—bone marrow—lung cancer	0.00398	0.0328	CbGeAlD
Gabapentin—BCAT1—lymph node—lung cancer	0.00374	0.0309	CbGeAlD
Gabapentin—CACNA2D1—lung—lung cancer	0.00361	0.0298	CbGeAlD
Gabapentin—ADORA1—lung—lung cancer	0.00348	0.0287	CbGeAlD
Gabapentin—CACNA2D2—lymph node—lung cancer	0.00343	0.0283	CbGeAlD
Gabapentin—CACNA2D1—lymph node—lung cancer	0.00247	0.0204	CbGeAlD
Gabapentin—ADORA1—lymph node—lung cancer	0.00238	0.0196	CbGeAlD
Gabapentin—CACNA2D2—Metabolism—ATP5H—lung cancer	0.000464	0.00245	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—RRM1—lung cancer	0.00044	0.00232	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTA3—lung cancer	0.00044	0.00232	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—AVP—lung cancer	0.000436	0.0023	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GRP—lung cancer	0.00043	0.00227	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—OXTR—lung cancer	0.00043	0.00227	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.000415	0.00219	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TYMS—lung cancer	0.000415	0.00219	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLBD1—lung cancer	0.000414	0.00218	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—B4GALT5—lung cancer	0.000414	0.00218	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000405	0.00214	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTA4—lung cancer	0.000402	0.00212	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GNG11—lung cancer	0.000402	0.00212	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000394	0.00208	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—MDM2—lung cancer	0.000392	0.00207	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTA2—lung cancer	0.000392	0.00207	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—RAF1—lung cancer	0.000391	0.00206	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSD17B10—lung cancer	0.000378	0.002	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTA1—lung cancer	0.000378	0.002	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCC3—lung cancer	0.000374	0.00197	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKR1C1—lung cancer	0.000362	0.00191	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CKB—lung cancer	0.000352	0.00185	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—UGT1A1—lung cancer	0.000352	0.00185	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GIPR—lung cancer	0.000347	0.00183	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000339	0.00179	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GNG11—lung cancer	0.000339	0.00179	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000338	0.00178	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTHLH—lung cancer	0.000336	0.00177	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM2—lung cancer	0.000331	0.00174	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CNDP2—lung cancer	0.000331	0.00174	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALDOA—lung cancer	0.000323	0.0017	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTMR3—lung cancer	0.000322	0.0017	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ANXA1—lung cancer	0.000316	0.00167	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GIPR—lung cancer	0.000315	0.00166	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PGAM1—lung cancer	0.000314	0.00165	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NCOA3—lung cancer	0.000314	0.00165	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—BRAF—lung cancer	0.00031	0.00164	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.000306	0.00161	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ADCY1—lung cancer	0.000305	0.00161	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCG2—lung cancer	0.000305	0.00161	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—APP—lung cancer	0.0003	0.00158	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2A7—lung cancer	0.000299	0.00158	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ENO2—lung cancer	0.000299	0.00158	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HPGDS—lung cancer	0.000299	0.00158	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPP2R1B—lung cancer	0.000297	0.00157	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GRM8—lung cancer	0.000295	0.00155	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SDC4—lung cancer	0.000293	0.00154	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTT1—lung cancer	0.00029	0.00153	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GCLC—lung cancer	0.000287	0.00151	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP2A6—lung cancer	0.000287	0.00151	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—HRAS—lung cancer	0.000281	0.00148	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ENO1—lung cancer	0.000272	0.00143	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GRM8—lung cancer	0.000268	0.00141	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—RRM1—lung cancer	0.000267	0.00141	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA3—lung cancer	0.000267	0.00141	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—MDM2—lung cancer	0.00026	0.00137	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—RAF1—lung cancer	0.000259	0.00137	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—POMC—lung cancer	0.000256	0.00135	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—B4GALT5—lung cancer	0.000251	0.00132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AXL—lung cancer	0.000246	0.00129	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA4—lung cancer	0.000244	0.00129	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP2E1—lung cancer	0.000244	0.00129	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—OXTR—lung cancer	0.000243	0.00128	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GRP—lung cancer	0.000243	0.00128	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NQO1—lung cancer	0.000241	0.00127	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA2—lung cancer	0.000238	0.00125	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AVP—lung cancer	0.000233	0.00123	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA1—lung cancer	0.000229	0.00121	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNG11—lung cancer	0.000227	0.0012	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCC3—lung cancer	0.000227	0.0012	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—OXTR—lung cancer	0.000221	0.00116	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GRP—lung cancer	0.000221	0.00116	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKR1C1—lung cancer	0.00022	0.00116	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—STK11—lung cancer	0.000217	0.00115	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—HRAS—lung cancer	0.000215	0.00114	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—UGT1A1—lung cancer	0.000213	0.00112	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—JUN—lung cancer	0.000208	0.0011	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNG11—lung cancer	0.000206	0.00109	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNG11—lung cancer	0.000206	0.00108	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADCY1—lung cancer	0.000204	0.00108	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000203	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—lung cancer	0.000202	0.00106	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTP1—lung cancer	0.000201	0.00106	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL8—lung cancer	0.000198	0.00104	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAT—lung cancer	0.000196	0.00103	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALDOA—lung cancer	0.000196	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—EP300—lung cancer	0.000192	0.00101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—COL4A2—lung cancer	0.000191	0.00101	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCB1—lung cancer	0.00019	0.001	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTHLH—lung cancer	0.00019	0.001	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA3—lung cancer	0.00019	0.001	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TYMS—lung cancer	0.000187	0.000986	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000186	0.000982	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GIPR—lung cancer	0.000186	0.000981	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADCY1—lung cancer	0.000186	0.000979	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ADCY1—lung cancer	0.000185	0.000974	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCG2—lung cancer	0.000185	0.000974	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTM1—lung cancer	0.000185	0.000974	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ENO2—lung cancer	0.000181	0.000955	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HPGDS—lung cancer	0.000181	0.000955	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PPP2R1B—lung cancer	0.000181	0.000954	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPP2R1B—lung cancer	0.00018	0.000949	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ANXA1—lung cancer	0.000179	0.000942	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTT1—lung cancer	0.000176	0.000927	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1A1—lung cancer	0.000175	0.000924	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCLC—lung cancer	0.000174	0.000916	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2A6—lung cancer	0.000174	0.000916	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ERCC2—lung cancer	0.000174	0.000916	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SDC4—lung cancer	0.000174	0.000916	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTHLH—lung cancer	0.000173	0.00091	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DUSP3—lung cancer	0.00017	0.000897	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—APP—lung cancer	0.000169	0.000893	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RHEB—lung cancer	0.000167	0.00088	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ENO1—lung cancer	0.000165	0.000868	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ANXA1—lung cancer	0.000162	0.000855	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRM8—lung cancer	0.000158	0.000834	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000157	0.00083	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—POMC—lung cancer	0.000155	0.000817	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—APP—lung cancer	0.000154	0.000811	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SKI—lung cancer	0.000153	0.000808	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOA1—lung cancer	0.00015	0.000792	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2E1—lung cancer	0.000148	0.000779	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NQO1—lung cancer	0.000146	0.00077	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—lung cancer	0.000143	0.000752	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—lung cancer	0.000138	0.000726	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—lung cancer	0.000137	0.000723	CbGpPWpGaD
Gabapentin—Pruritus—Gemcitabine—lung cancer	0.000133	0.000193	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PXN—lung cancer	0.000133	0.000701	CbGpPWpGaD
Gabapentin—Urethral disorder—Methotrexate—lung cancer	0.000133	0.000193	CcSEcCtD
Gabapentin—Infection—Docetaxel—lung cancer	0.000133	0.000193	CcSEcCtD
Gabapentin—Weight decreased—Doxorubicin—lung cancer	0.000133	0.000193	CcSEcCtD
Gabapentin—Feeling abnormal—Etoposide—lung cancer	0.000133	0.000192	CcSEcCtD
Gabapentin—Hyperglycaemia—Doxorubicin—lung cancer	0.000132	0.000192	CcSEcCtD
Gabapentin—Diarrhoea—Irinotecan—lung cancer	0.000132	0.000192	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—AVP—lung cancer	0.000132	0.000694	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—STK11—lung cancer	0.000132	0.000694	CbGpPWpGaD
Gabapentin—Pneumonia—Doxorubicin—lung cancer	0.000132	0.000191	CcSEcCtD
Gabapentin—Gastrointestinal pain—Etoposide—lung cancer	0.000132	0.000191	CcSEcCtD
Gabapentin—Shock—Docetaxel—lung cancer	0.000132	0.000191	CcSEcCtD
Gabapentin—Nervous system disorder—Docetaxel—lung cancer	0.000131	0.00019	CcSEcCtD
Gabapentin—Thrombocytopenia—Docetaxel—lung cancer	0.000131	0.00019	CcSEcCtD
Gabapentin—Infestation—Doxorubicin—lung cancer	0.000131	0.00019	CcSEcCtD
Gabapentin—Drowsiness—Doxorubicin—lung cancer	0.000131	0.00019	CcSEcCtD
Gabapentin—Infestation NOS—Doxorubicin—lung cancer	0.000131	0.00019	CcSEcCtD
Gabapentin—Visual impairment—Methotrexate—lung cancer	0.000131	0.00019	CcSEcCtD
Gabapentin—BCAT1—Metabolism—POMC—lung cancer	0.000131	0.000689	CbGpPWpGaD
Gabapentin—Tachycardia—Docetaxel—lung cancer	0.000131	0.000189	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—OXTR—lung cancer	0.00013	0.000687	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKR1C1—lung cancer	0.00013	0.000687	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRP—lung cancer	0.00013	0.000687	CbGpPWpGaD
Gabapentin—Feeling abnormal—Paclitaxel—lung cancer	0.00013	0.000189	CcSEcCtD
Gabapentin—Skin disorder—Docetaxel—lung cancer	0.00013	0.000189	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00013	0.000188	CcSEcCtD
Gabapentin—Hypersensitivity—Cisplatin—lung cancer	0.000129	0.000188	CcSEcCtD
Gabapentin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000129	0.000187	CcSEcCtD
Gabapentin—Diarrhoea—Gemcitabine—lung cancer	0.000129	0.000187	CcSEcCtD
Gabapentin—Renal failure—Doxorubicin—lung cancer	0.000129	0.000187	CcSEcCtD
Gabapentin—Erythema multiforme—Methotrexate—lung cancer	0.000128	0.000186	CcSEcCtD
Gabapentin—Neuropathy peripheral—Doxorubicin—lung cancer	0.000128	0.000186	CcSEcCtD
Gabapentin—Dizziness—Irinotecan—lung cancer	0.000128	0.000186	CcSEcCtD
Gabapentin—Urticaria—Etoposide—lung cancer	0.000128	0.000186	CcSEcCtD
Gabapentin—Stomatitis—Doxorubicin—lung cancer	0.000128	0.000185	CcSEcCtD
Gabapentin—Jaundice—Doxorubicin—lung cancer	0.000128	0.000185	CcSEcCtD
Gabapentin—Anorexia—Docetaxel—lung cancer	0.000127	0.000185	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CREBBP—lung cancer	0.000127	0.000671	CbGpPWpGaD
Gabapentin—Body temperature increased—Etoposide—lung cancer	0.000127	0.000185	CcSEcCtD
Gabapentin—Abdominal pain—Etoposide—lung cancer	0.000127	0.000185	CcSEcCtD
Gabapentin—Urinary tract infection—Doxorubicin—lung cancer	0.000127	0.000185	CcSEcCtD
Gabapentin—Conjunctivitis—Doxorubicin—lung cancer	0.000127	0.000185	CcSEcCtD
Gabapentin—Eye disorder—Methotrexate—lung cancer	0.000127	0.000184	CcSEcCtD
Gabapentin—Tinnitus—Methotrexate—lung cancer	0.000126	0.000184	CcSEcCtD
Gabapentin—Asthenia—Cisplatin—lung cancer	0.000126	0.000183	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—lung cancer	0.000126	0.000664	CbGpPWpGaD
Gabapentin—Cardiac disorder—Methotrexate—lung cancer	0.000126	0.000183	CcSEcCtD
Gabapentin—Sweating—Doxorubicin—lung cancer	0.000125	0.000182	CcSEcCtD
Gabapentin—Urticaria—Paclitaxel—lung cancer	0.000125	0.000182	CcSEcCtD
Gabapentin—Hypotension—Docetaxel—lung cancer	0.000125	0.000181	CcSEcCtD
Gabapentin—Haematuria—Doxorubicin—lung cancer	0.000125	0.000181	CcSEcCtD
Gabapentin—Body temperature increased—Paclitaxel—lung cancer	0.000125	0.000181	CcSEcCtD
Gabapentin—Abdominal pain—Paclitaxel—lung cancer	0.000125	0.000181	CcSEcCtD
Gabapentin—Hepatobiliary disease—Doxorubicin—lung cancer	0.000124	0.00018	CcSEcCtD
Gabapentin—Epistaxis—Doxorubicin—lung cancer	0.000123	0.000179	CcSEcCtD
Gabapentin—Vomiting—Irinotecan—lung cancer	0.000123	0.000178	CcSEcCtD
Gabapentin—Sinusitis—Doxorubicin—lung cancer	0.000123	0.000178	CcSEcCtD
Gabapentin—Immune system disorder—Methotrexate—lung cancer	0.000123	0.000178	CcSEcCtD
Gabapentin—Mediastinal disorder—Methotrexate—lung cancer	0.000122	0.000177	CcSEcCtD
Gabapentin—Rash—Irinotecan—lung cancer	0.000122	0.000177	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—GNG11—lung cancer	0.000122	0.000643	CbGpPWpGaD
Gabapentin—Dermatitis—Irinotecan—lung cancer	0.000122	0.000177	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GSTP1—lung cancer	0.000122	0.000642	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000122	0.000177	CcSEcCtD
Gabapentin—Chills—Methotrexate—lung cancer	0.000122	0.000177	CcSEcCtD
Gabapentin—Headache—Irinotecan—lung cancer	0.000121	0.000176	CcSEcCtD
Gabapentin—Insomnia—Docetaxel—lung cancer	0.000121	0.000176	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PIK3CD—lung cancer	0.000121	0.000636	CbGpPWpGaD
Gabapentin—Diarrhoea—Cisplatin—lung cancer	0.00012	0.000174	CcSEcCtD
Gabapentin—Paraesthesia—Docetaxel—lung cancer	0.00012	0.000174	CcSEcCtD
Gabapentin—Alopecia—Methotrexate—lung cancer	0.00012	0.000174	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—lung cancer	0.00012	0.000632	CbGpPWpGaD
Gabapentin—Vomiting—Gemcitabine—lung cancer	0.00012	0.000174	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—AVP—lung cancer	0.00012	0.000631	CbGpPWpGaD
Gabapentin—Bradycardia—Doxorubicin—lung cancer	0.00012	0.000174	CcSEcCtD
Gabapentin—Dyspnoea—Docetaxel—lung cancer	0.000119	0.000173	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ALB—lung cancer	0.000119	0.000628	CbGpPWpGaD
Gabapentin—Somnolence—Docetaxel—lung cancer	0.000119	0.000173	CcSEcCtD
Gabapentin—Mental disorder—Methotrexate—lung cancer	0.000119	0.000172	CcSEcCtD
Gabapentin—Rash—Gemcitabine—lung cancer	0.000119	0.000172	CcSEcCtD
Gabapentin—Dermatitis—Gemcitabine—lung cancer	0.000119	0.000172	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CAT—lung cancer	0.000119	0.000625	CbGpPWpGaD
Gabapentin—Hypersensitivity—Etoposide—lung cancer	0.000119	0.000172	CcSEcCtD
Gabapentin—Erythema—Methotrexate—lung cancer	0.000118	0.000171	CcSEcCtD
Gabapentin—Malnutrition—Methotrexate—lung cancer	0.000118	0.000171	CcSEcCtD
Gabapentin—Headache—Gemcitabine—lung cancer	0.000118	0.000171	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—lung cancer	0.000118	0.000171	CcSEcCtD
Gabapentin—Dyspepsia—Docetaxel—lung cancer	0.000118	0.000171	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—lung cancer	0.000117	0.00017	CcSEcCtD
Gabapentin—Hepatitis—Doxorubicin—lung cancer	0.000117	0.00017	CcSEcCtD
Gabapentin—Hypoaesthesia—Doxorubicin—lung cancer	0.000117	0.00017	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—lung cancer	0.000117	0.000169	CcSEcCtD
Gabapentin—Decreased appetite—Docetaxel—lung cancer	0.000116	0.000169	CcSEcCtD
Gabapentin—Hypersensitivity—Paclitaxel—lung cancer	0.000116	0.000169	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—VEGFC—lung cancer	0.000116	0.000612	CbGpPWpGaD
Gabapentin—Urinary tract disorder—Doxorubicin—lung cancer	0.000116	0.000168	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—lung cancer	0.000116	0.000168	CcSEcCtD
Gabapentin—Dysgeusia—Methotrexate—lung cancer	0.000116	0.000168	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000115	0.000168	CcSEcCtD
Gabapentin—Asthenia—Etoposide—lung cancer	0.000115	0.000168	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—lung cancer	0.000115	0.000168	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ABCB1—lung cancer	0.000115	0.000608	CbGpPWpGaD
Gabapentin—Fatigue—Docetaxel—lung cancer	0.000115	0.000167	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—lung cancer	0.000115	0.000167	CcSEcCtD
Gabapentin—Nausea—Irinotecan—lung cancer	0.000115	0.000167	CcSEcCtD
Gabapentin—Pain—Docetaxel—lung cancer	0.000114	0.000166	CcSEcCtD
Gabapentin—Constipation—Docetaxel—lung cancer	0.000114	0.000166	CcSEcCtD
Gabapentin—Back pain—Methotrexate—lung cancer	0.000114	0.000166	CcSEcCtD
Gabapentin—Pruritus—Etoposide—lung cancer	0.000114	0.000165	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—TYMS—lung cancer	0.000113	0.000597	CbGpPWpGaD
Gabapentin—Visual impairment—Doxorubicin—lung cancer	0.000113	0.000164	CcSEcCtD
Gabapentin—Asthenia—Paclitaxel—lung cancer	0.000113	0.000164	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GSTM1—lung cancer	0.000112	0.00059	CbGpPWpGaD
Gabapentin—Nausea—Gemcitabine—lung cancer	0.000112	0.000162	CcSEcCtD
Gabapentin—Vomiting—Cisplatin—lung cancer	0.000112	0.000162	CcSEcCtD
Gabapentin—Pruritus—Paclitaxel—lung cancer	0.000112	0.000162	CcSEcCtD
Gabapentin—Vision blurred—Methotrexate—lung cancer	0.000111	0.000162	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—lung cancer	0.000111	0.000161	CcSEcCtD
Gabapentin—Rash—Cisplatin—lung cancer	0.000111	0.000161	CcSEcCtD
Gabapentin—Dermatitis—Cisplatin—lung cancer	0.000111	0.000161	CcSEcCtD
Gabapentin—Feeling abnormal—Docetaxel—lung cancer	0.00011	0.00016	CcSEcCtD
Gabapentin—Diarrhoea—Etoposide—lung cancer	0.00011	0.00016	CcSEcCtD
Gabapentin—Eye disorder—Doxorubicin—lung cancer	0.00011	0.000159	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ADCY1—lung cancer	0.00011	0.000578	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Methotrexate—lung cancer	0.00011	0.000159	CcSEcCtD
Gabapentin—Tinnitus—Doxorubicin—lung cancer	0.00011	0.000159	CcSEcCtD
Gabapentin—Gastrointestinal pain—Docetaxel—lung cancer	0.000109	0.000159	CcSEcCtD
Gabapentin—Anaemia—Methotrexate—lung cancer	0.000109	0.000158	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—lung cancer	0.000109	0.000158	CcSEcCtD
Gabapentin—Diarrhoea—Paclitaxel—lung cancer	0.000108	0.000157	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SMARCA4—lung cancer	0.000107	0.000563	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PPP2R1B—lung cancer	0.000107	0.000563	CbGpPWpGaD
Gabapentin—Malaise—Methotrexate—lung cancer	0.000106	0.000155	CcSEcCtD
Gabapentin—Dizziness—Etoposide—lung cancer	0.000106	0.000154	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP1A1—lung cancer	0.000106	0.00056	CbGpPWpGaD
Gabapentin—Immune system disorder—Doxorubicin—lung cancer	0.000106	0.000154	CcSEcCtD
Gabapentin—Vertigo—Methotrexate—lung cancer	0.000106	0.000154	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—lung cancer	0.000106	0.000154	CcSEcCtD
Gabapentin—Abdominal pain—Docetaxel—lung cancer	0.000106	0.000153	CcSEcCtD
Gabapentin—Body temperature increased—Docetaxel—lung cancer	0.000106	0.000153	CcSEcCtD
Gabapentin—Leukopenia—Methotrexate—lung cancer	0.000106	0.000153	CcSEcCtD
Gabapentin—Chills—Doxorubicin—lung cancer	0.000105	0.000153	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ERCC2—lung cancer	0.000105	0.000555	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—lung cancer	0.000105	0.000554	CbGpPWpGaD
Gabapentin—Dizziness—Paclitaxel—lung cancer	0.000104	0.000151	CcSEcCtD
Gabapentin—Nausea—Cisplatin—lung cancer	0.000104	0.000151	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PTGS2—lung cancer	0.000104	0.000549	CbGpPWpGaD
Gabapentin—Alopecia—Doxorubicin—lung cancer	0.000104	0.000151	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HSPB1—lung cancer	0.000103	0.000544	CbGpPWpGaD
Gabapentin—Cough—Methotrexate—lung cancer	0.000103	0.00015	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—lung cancer	0.000103	0.000149	CcSEcCtD
Gabapentin—Convulsion—Methotrexate—lung cancer	0.000102	0.000148	CcSEcCtD
Gabapentin—Vomiting—Etoposide—lung cancer	0.000102	0.000148	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—lung cancer	0.000102	0.000148	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—lung cancer	0.000102	0.000148	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PTHLH—lung cancer	0.000102	0.000537	CbGpPWpGaD
Gabapentin—Rash—Etoposide—lung cancer	0.000101	0.000147	CcSEcCtD
Gabapentin—Dermatitis—Etoposide—lung cancer	0.000101	0.000147	CcSEcCtD
Gabapentin—Headache—Etoposide—lung cancer	0.000101	0.000146	CcSEcCtD
Gabapentin—Flatulence—Doxorubicin—lung cancer	0.000101	0.000146	CcSEcCtD
Gabapentin—Chest pain—Methotrexate—lung cancer	0.000101	0.000146	CcSEcCtD
Gabapentin—Arthralgia—Methotrexate—lung cancer	0.000101	0.000146	CcSEcCtD
Gabapentin—Myalgia—Methotrexate—lung cancer	0.000101	0.000146	CcSEcCtD
Gabapentin—Tension—Doxorubicin—lung cancer	0.0001	0.000146	CcSEcCtD
Gabapentin—Vomiting—Paclitaxel—lung cancer	0.0001	0.000146	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—lung cancer	0.0001	0.000145	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.98e-05	0.000145	CcSEcCtD
Gabapentin—Rash—Paclitaxel—lung cancer	9.95e-05	0.000144	CcSEcCtD
Gabapentin—Dermatitis—Paclitaxel—lung cancer	9.94e-05	0.000144	CcSEcCtD
Gabapentin—Discomfort—Methotrexate—lung cancer	9.93e-05	0.000144	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—lung cancer	9.93e-05	0.000144	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—lung cancer	9.89e-05	0.000144	CcSEcCtD
Gabapentin—Headache—Paclitaxel—lung cancer	9.88e-05	0.000143	CcSEcCtD
Gabapentin—Hypersensitivity—Docetaxel—lung cancer	9.85e-05	0.000143	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—lung cancer	9.83e-05	0.000143	CcSEcCtD
Gabapentin—Confusional state—Methotrexate—lung cancer	9.72e-05	0.000141	CcSEcCtD
Gabapentin—Anaphylactic shock—Methotrexate—lung cancer	9.64e-05	0.00014	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—lung cancer	9.64e-05	0.00014	CcSEcCtD
Gabapentin—Asthenia—Docetaxel—lung cancer	9.59e-05	0.000139	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ANXA1—lung cancer	9.58e-05	0.000505	CbGpPWpGaD
Gabapentin—Infection—Methotrexate—lung cancer	9.57e-05	0.000139	CcSEcCtD
Gabapentin—Nausea—Etoposide—lung cancer	9.56e-05	0.000139	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—lung cancer	9.49e-05	0.000138	CcSEcCtD
Gabapentin—Pruritus—Docetaxel—lung cancer	9.46e-05	0.000137	CcSEcCtD
Gabapentin—Nervous system disorder—Methotrexate—lung cancer	9.45e-05	0.000137	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—lung cancer	9.45e-05	0.000137	CcSEcCtD
Gabapentin—Thrombocytopenia—Methotrexate—lung cancer	9.44e-05	0.000137	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—lung cancer	9.4e-05	0.000136	CcSEcCtD
Gabapentin—Nausea—Paclitaxel—lung cancer	9.37e-05	0.000136	CcSEcCtD
Gabapentin—Skin disorder—Methotrexate—lung cancer	9.36e-05	0.000136	CcSEcCtD
Gabapentin—Hyperhidrosis—Methotrexate—lung cancer	9.32e-05	0.000135	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FLT1—lung cancer	9.28e-05	0.000489	CbGpPWpGaD
Gabapentin—Malaise—Doxorubicin—lung cancer	9.22e-05	0.000134	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—lung cancer	9.2e-05	0.000485	CbGpPWpGaD
Gabapentin—Vertigo—Doxorubicin—lung cancer	9.19e-05	0.000133	CcSEcCtD
Gabapentin—Anorexia—Methotrexate—lung cancer	9.19e-05	0.000133	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—lung cancer	9.17e-05	0.000133	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—lung cancer	9.15e-05	0.000133	CcSEcCtD
Gabapentin—Diarrhoea—Docetaxel—lung cancer	9.15e-05	0.000133	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—APOA1—lung cancer	9.11e-05	0.00048	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH3—lung cancer	9.09e-05	0.000479	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APP—lung cancer	9.09e-05	0.000479	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—lung cancer	9.09e-05	0.000479	CbGpPWpGaD
Gabapentin—Palpitations—Doxorubicin—lung cancer	9.04e-05	0.000131	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGF9—lung cancer	9.01e-05	0.000475	CbGpPWpGaD
Gabapentin—Hypotension—Methotrexate—lung cancer	9.01e-05	0.000131	CcSEcCtD
Gabapentin—Loss of consciousness—Doxorubicin—lung cancer	8.99e-05	0.00013	CcSEcCtD
Gabapentin—Cough—Doxorubicin—lung cancer	8.92e-05	0.000129	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—lung cancer	8.86e-05	0.000129	CcSEcCtD
Gabapentin—Dizziness—Docetaxel—lung cancer	8.84e-05	0.000128	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—lung cancer	8.83e-05	0.000128	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Methotrexate—lung cancer	8.78e-05	0.000127	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—POMC—lung cancer	8.75e-05	0.000462	CbGpPWpGaD
Gabapentin—Insomnia—Methotrexate—lung cancer	8.72e-05	0.000127	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—lung cancer	8.71e-05	0.000126	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—lung cancer	8.71e-05	0.000126	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—lung cancer	8.71e-05	0.000126	CcSEcCtD
Gabapentin—Anxiety—Doxorubicin—lung cancer	8.68e-05	0.000126	CcSEcCtD
Gabapentin—BCAT1—Metabolism—EP300—lung cancer	8.66e-05	0.000457	CbGpPWpGaD
Gabapentin—Paraesthesia—Methotrexate—lung cancer	8.65e-05	0.000126	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.65e-05	0.000125	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—JUNB—lung cancer	8.6e-05	0.000454	CbGpPWpGaD
Gabapentin—Discomfort—Doxorubicin—lung cancer	8.6e-05	0.000125	CcSEcCtD
Gabapentin—Dyspnoea—Methotrexate—lung cancer	8.59e-05	0.000125	CcSEcCtD
Gabapentin—Somnolence—Methotrexate—lung cancer	8.57e-05	0.000124	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—lung cancer	8.51e-05	0.000124	CcSEcCtD
Gabapentin—Vomiting—Docetaxel—lung cancer	8.5e-05	0.000123	CcSEcCtD
Gabapentin—Dyspepsia—Methotrexate—lung cancer	8.48e-05	0.000123	CcSEcCtD
Gabapentin—Rash—Docetaxel—lung cancer	8.43e-05	0.000122	CcSEcCtD
Gabapentin—Dermatitis—Docetaxel—lung cancer	8.42e-05	0.000122	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—lung cancer	8.41e-05	0.000122	CcSEcCtD
Gabapentin—Decreased appetite—Methotrexate—lung cancer	8.38e-05	0.000122	CcSEcCtD
Gabapentin—Headache—Docetaxel—lung cancer	8.38e-05	0.000122	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—lung cancer	8.35e-05	0.00044	CbGpPWpGaD
Gabapentin—Anaphylactic shock—Doxorubicin—lung cancer	8.35e-05	0.000121	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—lung cancer	8.35e-05	0.000121	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Methotrexate—lung cancer	8.32e-05	0.000121	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—lung cancer	8.31e-05	0.000438	CbGpPWpGaD
Gabapentin—Fatigue—Methotrexate—lung cancer	8.31e-05	0.000121	CcSEcCtD
Gabapentin—Infection—Doxorubicin—lung cancer	8.29e-05	0.00012	CcSEcCtD
Gabapentin—Pain—Methotrexate—lung cancer	8.24e-05	0.00012	CcSEcCtD
Gabapentin—Shock—Doxorubicin—lung cancer	8.21e-05	0.000119	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—lung cancer	8.18e-05	0.000119	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—lung cancer	8.17e-05	0.000119	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—lung cancer	8.15e-05	0.000118	CcSEcCtD
Gabapentin—Skin disorder—Doxorubicin—lung cancer	8.11e-05	0.000118	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—lung cancer	8.08e-05	0.000426	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Doxorubicin—lung cancer	8.07e-05	0.000117	CcSEcCtD
Gabapentin—Anorexia—Doxorubicin—lung cancer	7.96e-05	0.000115	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—POMC—lung cancer	7.95e-05	0.000419	CbGpPWpGaD
Gabapentin—Nausea—Docetaxel—lung cancer	7.94e-05	0.000115	CcSEcCtD
Gabapentin—Feeling abnormal—Methotrexate—lung cancer	7.94e-05	0.000115	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—POMC—lung cancer	7.91e-05	0.000417	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Methotrexate—lung cancer	7.88e-05	0.000114	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—STK11—lung cancer	7.81e-05	0.000412	CbGpPWpGaD
Gabapentin—Hypotension—Doxorubicin—lung cancer	7.8e-05	0.000113	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—IL6R—lung cancer	7.75e-05	0.000409	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CREBBP—lung cancer	7.71e-05	0.000406	CbGpPWpGaD
Gabapentin—Urticaria—Methotrexate—lung cancer	7.66e-05	0.000111	CcSEcCtD
Gabapentin—Abdominal pain—Methotrexate—lung cancer	7.62e-05	0.000111	CcSEcCtD
Gabapentin—Body temperature increased—Methotrexate—lung cancer	7.62e-05	0.000111	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.6e-05	0.00011	CcSEcCtD
Gabapentin—Insomnia—Doxorubicin—lung cancer	7.55e-05	0.00011	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FOXO3—lung cancer	7.54e-05	0.000398	CbGpPWpGaD
Gabapentin—Paraesthesia—Doxorubicin—lung cancer	7.49e-05	0.000109	CcSEcCtD
Gabapentin—Dyspnoea—Doxorubicin—lung cancer	7.44e-05	0.000108	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—lung cancer	7.42e-05	0.000108	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—MAP2K1—lung cancer	7.39e-05	0.00039	CbGpPWpGaD
Gabapentin—Dyspepsia—Doxorubicin—lung cancer	7.35e-05	0.000107	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—lung cancer	7.34e-05	0.000387	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—lung cancer	7.31e-05	0.000385	CbGpPWpGaD
Gabapentin—Decreased appetite—Doxorubicin—lung cancer	7.25e-05	0.000105	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ALB—lung cancer	7.21e-05	0.00038	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Doxorubicin—lung cancer	7.2e-05	0.000105	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—lung cancer	7.2e-05	0.000104	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—lung cancer	7.14e-05	0.000104	CcSEcCtD
Gabapentin—Pain—Doxorubicin—lung cancer	7.14e-05	0.000104	CcSEcCtD
Gabapentin—Hypersensitivity—Methotrexate—lung cancer	7.1e-05	0.000103	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—AVP—lung cancer	7.07e-05	0.000373	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—lung cancer	7.05e-05	0.000372	CbGpPWpGaD
Gabapentin—Asthenia—Methotrexate—lung cancer	6.91e-05	0.0001	CcSEcCtD
Gabapentin—Feeling abnormal—Doxorubicin—lung cancer	6.88e-05	9.98e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—lung cancer	6.82e-05	9.9e-05	CcSEcCtD
Gabapentin—Pruritus—Methotrexate—lung cancer	6.82e-05	9.9e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—IGF1R—lung cancer	6.8e-05	0.000359	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—lung cancer	6.77e-05	0.000357	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HES1—lung cancer	6.68e-05	0.000352	CbGpPWpGaD
Gabapentin—Urticaria—Doxorubicin—lung cancer	6.63e-05	9.62e-05	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—lung cancer	6.6e-05	9.57e-05	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—lung cancer	6.6e-05	9.57e-05	CcSEcCtD
Gabapentin—Diarrhoea—Methotrexate—lung cancer	6.59e-05	9.57e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—RAF1—lung cancer	6.55e-05	0.000346	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—lung cancer	6.47e-05	0.000341	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—lung cancer	6.41e-05	0.000338	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—lung cancer	6.4e-05	0.000337	CbGpPWpGaD
Gabapentin—Dizziness—Methotrexate—lung cancer	6.37e-05	9.25e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—lung cancer	6.37e-05	0.000336	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—lung cancer	6.31e-05	0.000333	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—lung cancer	6.15e-05	0.000324	CbGpPWpGaD
Gabapentin—Hypersensitivity—Doxorubicin—lung cancer	6.15e-05	8.92e-05	CcSEcCtD
Gabapentin—Vomiting—Methotrexate—lung cancer	6.13e-05	8.89e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ERBB3—lung cancer	6.11e-05	0.000322	CbGpPWpGaD
Gabapentin—Rash—Methotrexate—lung cancer	6.08e-05	8.82e-05	CcSEcCtD
Gabapentin—Dermatitis—Methotrexate—lung cancer	6.07e-05	8.81e-05	CcSEcCtD
Gabapentin—Headache—Methotrexate—lung cancer	6.04e-05	8.76e-05	CcSEcCtD
Gabapentin—Asthenia—Doxorubicin—lung cancer	5.99e-05	8.69e-05	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—lung cancer	5.9e-05	8.57e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—IL2—lung cancer	5.88e-05	0.00031	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—lung cancer	5.86e-05	0.000309	CbGpPWpGaD
Gabapentin—Nausea—Methotrexate—lung cancer	5.72e-05	8.31e-05	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—lung cancer	5.71e-05	8.29e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGFR1—lung cancer	5.69e-05	0.0003	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—lung cancer	5.6e-05	0.000295	CbGpPWpGaD
Gabapentin—Dizziness—Doxorubicin—lung cancer	5.52e-05	8.01e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PTEN—lung cancer	5.5e-05	0.00029	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA1—lung cancer	5.4e-05	0.000285	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KDR—lung cancer	5.36e-05	0.000282	CbGpPWpGaD
Gabapentin—Vomiting—Doxorubicin—lung cancer	5.31e-05	7.7e-05	CcSEcCtD
Gabapentin—Rash—Doxorubicin—lung cancer	5.26e-05	7.64e-05	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—lung cancer	5.26e-05	7.63e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—EP300—lung cancer	5.25e-05	0.000277	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—lung cancer	5.24e-05	0.000276	CbGpPWpGaD
Gabapentin—Headache—Doxorubicin—lung cancer	5.23e-05	7.59e-05	CcSEcCtD
Gabapentin—Nausea—Doxorubicin—lung cancer	4.96e-05	7.19e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—APC—lung cancer	4.93e-05	0.00026	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—lung cancer	4.93e-05	0.00026	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KIT—lung cancer	4.93e-05	0.00026	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NRAS—lung cancer	4.93e-05	0.00026	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGF—lung cancer	4.88e-05	0.000257	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK3—lung cancer	4.72e-05	0.000249	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—POMC—lung cancer	4.7e-05	0.000248	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BRAF—lung cancer	4.64e-05	0.000244	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6R—lung cancer	4.58e-05	0.000242	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CREBBP—lung cancer	4.57e-05	0.000241	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—lung cancer	4.49e-05	0.000237	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAP2K1—lung cancer	4.37e-05	0.00023	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—lung cancer	4.34e-05	0.000229	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—lung cancer	4.3e-05	0.000226	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—lung cancer	4.25e-05	0.000224	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—lung cancer	3.9e-05	0.000206	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MDM2—lung cancer	3.89e-05	0.000205	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—lung cancer	3.88e-05	0.000205	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAF1—lung cancer	3.87e-05	0.000204	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB2—lung cancer	3.83e-05	0.000202	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—lung cancer	3.78e-05	0.000199	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTOR—lung cancer	3.78e-05	0.000199	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—lung cancer	3.63e-05	0.000192	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—lung cancer	3.61e-05	0.00019	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—lung cancer	3.51e-05	0.000185	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—lung cancer	3.48e-05	0.000183	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—lung cancer	3.47e-05	0.000183	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—lung cancer	3.45e-05	0.000182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—lung cancer	3.38e-05	0.000178	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JUN—lung cancer	3.38e-05	0.000178	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—lung cancer	3.29e-05	0.000173	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1A—lung cancer	3.27e-05	0.000173	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—lung cancer	3.27e-05	0.000172	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—lung cancer	3.19e-05	0.000168	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—lung cancer	3.17e-05	0.000167	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EP300—lung cancer	3.12e-05	0.000164	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SRC—lung cancer	3.03e-05	0.00016	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—lung cancer	2.95e-05	0.000156	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—lung cancer	2.92e-05	0.000154	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRAS—lung cancer	2.91e-05	0.000154	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK3—lung cancer	2.79e-05	0.000147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—lung cancer	2.71e-05	0.000143	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—lung cancer	2.66e-05	0.00014	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—lung cancer	2.51e-05	0.000132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—lung cancer	2.3e-05	0.000121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—lung cancer	2.23e-05	0.000118	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—lung cancer	2.13e-05	0.000112	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—lung cancer	2.04e-05	0.000108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—lung cancer	1.88e-05	9.92e-05	CbGpPWpGaD
